Skip to main content
OpenTrials

Clinical trial condition

Hypophosphatasia

Explore clinical trials studying Hypophosphatasia. Study availability and eligibility vary by location and protocol.

35 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Hypophosphatasia trial results

Active, not recruiting

Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP

NCT06079359

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hypophosphatasia, +4 more
Locations
  • Research Site Baltimore, Maryland, United States
  • Research Site Kansas City, Missouri, United States
  • Research Site Durham, North Carolina, United States
  • Research Site Nedlands, Australia
View all 32 locations
View Trial Details
Active, not recruiting

Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa

NCT06079372

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hypophosphatasia, +4 more
Locations
  • Research Site Hartford, Connecticut, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Minneapolis, Minnesota, United States
  • Research Site Kansas City, Missouri, United States
View all 21 locations
View Trial Details
Completed

Study of ALXN1850 in Participants With Hypophosphatasia (HPP)

NCT04980248

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hypophosphatasia, +4 more
Locations
  • Research Site Las Vegas, Nevada, United States
  • Research Site Columbus, Ohio, United States
  • Research Site Nashville, Tennessee, United States
  • Research Site Austin, Texas, United States
View Trial Details

Related conditions